The relationship of weight suppression to treatment outcomes during behavioral weight loss.
The relationship of weight suppression to treatment outcomes during behavioral weight loss.
复制标题
DOI：
10.1007/s10865-018-9978-8
复制
发表时间：
2019-04
影响因子：
3.1
通讯作者：
Butryn ML
中科院分区：
文献类型：
--
作者：
Call CC;Piers AD;Wyckoff EP;Lowe MR;Forman EM;Butryn ML
许多成年人进入行为减肥（BWL）计划时的体重低于他们一生中的最高体重。最高终身体重和当前体重之间的差异称为体重抑制（WS）。研究尚未描述BWL期间WS的特征或调查其与体重减轻结局或治疗可接受性的关系。评估了12个月BWL计划中的成人（N = 272）。通过从自我报告的最高终身体重中减去测量的基线体重来计算WS。在治疗期间，具有较高WS的参与者比具有较低WS的参与者体重减轻显著更少，尽管他们仍然具有临床意义的体重减轻（例如，WS高于中位数的受试者：7.8 kg; WS低于中位数的受试者：12.0 kg）。在24个月随访时，WS与体重减轻无关。控制体重减轻，治疗的可接受性与WS无关。BWL似乎适用于高WS的患者，但未来的研究应旨在改善该组的结局。
Many adults enter behavioral weight loss (BWL) programs at a weight below their highest lifetime weight. The discrepancy between highest lifetime weight and current weight is known as weight suppression (WS). Research has yet to characterize WS during BWL or investigate its relation to weight loss outcomes or treatment acceptability. Adults (N = 272) in a 12-month BWL program were assessed. WS was calculated by subtracting measured baseline weight from self-reported highest lifetime weight. Participants with higher WS lost significantly less weight than those with lower WS during treatment, although they still had clinically meaningful weight losses (e.g., participants with WS above the median: 7.8 kg; participants with WS below the median: 12.0 kg). WS was unrelated to weight losses at 24-month follow-up. Controlling for weight loss, treatment acceptability was unrelated to WS. BWL appears appropriate for those with high WS, but future research should aim to improve outcomes in this group.
登录
查看更多内容
影响因子：
37.8
作者：
Jensen MD;Ryan DH;Apovian CM;Ard JD;Comuzzie AG;Donato KA;Hu FB;Hubbard VS;Jakicic JM;Kushner RF;Loria CM;Millen BE;Nonas CA;Pi-Sunyer FX;Stevens J;Stevens VJ;Wadden TA;Wolfe BM;Yanovski SZ;Jordan HS;Kendall KA;Lux LJ;Mentor-Marcel R;Morgan LC;Trisolini MG;Wnek J;Anderson JL;Halperin JL;Albert NM;Bozkurt B;Brindis RG;Curtis LH;DeMets D;Hochman JS;Kovacs RJ;Ohman EM;Pressler SJ;Sellke FW;Shen WK;Smith SC Jr;Tomaselli GF;American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Obesity Society
通讯作者：
Obesity Society
DOI：
10.1136/bmj.g2646
发表时间：
2014-05-14
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Dombrowski SU;Knittle K;Avenell A;Araújo-Soares V;Sniehotta FF
通讯作者：
Sniehotta FF
影响因子：
6.9
作者：
Forman, E. M.;Butryn, M. L.;Shaw, J. A.
通讯作者：
Shaw, J. A.
影响因子：
4.9
作者：
Gilhooly, C. H.;Das, S. K.;Roberts, S. B.
通讯作者：
Roberts, S. B.
影响因子：
5.5
作者：
Carter, Frances A.;Boden, Joseph M.;Joyce, Peter R.
通讯作者：
Joyce, Peter R.